Nanofiber-based systems intended for diabetes.
Hassan MalekiKamyar KhoshnevisanSayed Mahmoud Sajjadi-JaziHadi BaharifarMaryam DoostanNazanin KhoshnevisanFarshad SharifiPublished in: Journal of nanobiotechnology (2021)
Diabetic mellitus (DM) is the most communal metabolic disease resulting from a defect in insulin secretion, causing hyperglycemia by promoting the progressive destruction of pancreatic β cells. This autoimmune disease causes many severe disorders leading to organ failure, lower extremity amputations, and ultimately death. Modern delivery systems e.g., nanofiber (NF)-based systems fabricated by natural and synthetic or both materials to deliver therapeutics agents and cells, could be the harbinger of a new era to obviate DM complications. Such delivery systems can effectively deliver macromolecules (insulin) and small molecules. Besides, NF scaffolds can provide an ideal microenvironment to cell therapy for pancreatic β cell transplantation and pancreatic tissue engineering. Numerous studies indicated the potential usage of therapeutics/cells-incorporated NF mats to proliferate/regenerate/remodeling the structural and functional properties of diabetic skin ulcers. Thus, we intended to discuss the aforementioned features of the NF system for DM complications in detail.
Keyphrases
- induced apoptosis
- signaling pathway
- type diabetes
- cell cycle arrest
- pi k akt
- tissue engineering
- lps induced
- oxidative stress
- glycemic control
- multiple sclerosis
- nuclear factor
- single cell
- stem cells
- wound healing
- endoplasmic reticulum stress
- cell therapy
- cell death
- risk factors
- adipose tissue
- weight loss
- inflammatory response
- bone marrow